Funds from The National Centre for Research and Development

The National Centre for Research and Development and grant TECHMATSTRATEG-III/0042/2019 (2020-2023) to the Consortium, led by the Warsaw University of Technology was in part obtained as based on BioVentures Institute technology for construction of concatemeric proteins: „Biopolymer materials with chemically and genetically programmed heavy metal selectivity for new generation ultra-sensitive biosensors. Amount of funding: 4.5 mln Euro.

Patent for EU

Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with European Union patent no EP 3 134 426 B1.

Patent EP 3 134 426 B1

.pdf

Download PDF • 1.91MB

New publication in MethodsX international journal

Detailed laboratory protocols, concerning the patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology have been published in the MethodsX international journal (MethodsX 7, 2020, 7:101070).

MethodsX international journal

.pdf

Download PDF • 2.14MB